Log in

OTCMKTS:OXYS - OxySure Therapeutics Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
0.00 (0.00 %)
(As of 07/25/2018)
Today's Range
Now: $0.03
50-Day Range N/A
52-Week Range
Now: $0.03
Volume53,810 shs
Average Volume135,131 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
OxySure Therapeutics, Inc. designs, manufactures, and distributes specialty respiratory and emergency medical solutions in the United States and internationally. It offers OxySure Model 615, a portable emergency oxygen system. The company also provides complimentary products and solutions, including display wall boxes, oxygen wall signage, resuscitation bags, pulse oximeters, and automated external defibrillators, as well as thermal bags and replacement cartridges for its OxySure Model 615. Its products enhance the access to emergency oxygen that affects the survival, recovery, and safety of individuals in various areas of need. The company primarily sells its products to institutional customers through distributors, sub-distributors, and sales agents. The company was formerly known as OxySure Systems, Inc. and changed its name to OxySure Therapeutics, Inc. in November 2015. OxySure Therapeutics, Inc. was founded in 2004 and is headquartered in Frisco, Texas. On December 5, 2016, Oxysure Therapeutics, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the Eastern District of Texas.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolOTCMKTS:OXYS



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive OXYS News and Ratings via Email

Sign-up to receive the latest news and ratings for OXYS and its competitors with MarketBeat's FREE daily newsletter.

OxySure Therapeutics (OTCMKTS:OXYS) Frequently Asked Questions

What is OxySure Therapeutics' stock symbol?

OxySure Therapeutics trades on the OTCMKTS under the ticker symbol "OXYS."

Has OxySure Therapeutics been receiving favorable news coverage?

Media headlines about OXYS stock have trended very negative recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. OxySure Therapeutics earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for OxySure Therapeutics.

Who are some of OxySure Therapeutics' key competitors?

What other stocks do shareholders of OxySure Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OxySure Therapeutics investors own include IDEXX Laboratories (IDXX), Enterprise GP (EPE), Energy Fuels (UUUU), JetBlue Airways (JBLU), CD International Enterprises (CDII), Terra Tech (TRTC), Canabo Medical (CMM), Himax Technologies (HIMX), Cesca Therapeutics (KOOL) and ZIOPHARM Oncology (ZIOP).

Who are OxySure Therapeutics' key executives?

OxySure Therapeutics' management team includes the folowing people:
  • Mr. Julian T. Ross M.B.A., Founder, Chairman, CEO, Pres, CFO, Principal Accounting Officer and Sec. (Age 51)
  • Ms. Lisa Griffin, Director of Safety Education
  • Ms. Kathryn Jayne, Director of Regulatory Affairs & Quality Assurance

What is OxySure Therapeutics' stock price today?

One share of OXYS stock can currently be purchased for approximately $0.03.

What is OxySure Therapeutics' official website?

The official website for OxySure Therapeutics is http://www.oxysure.com/.

How can I contact OxySure Therapeutics?

OxySure Therapeutics' mailing address is 10880 JOHN W. ELLIOTT ROAD SUITE 600, Frisco TX, 75033. The company can be reached via phone at 972-294-6450 or via email at [email protected]

MarketBeat Community Rating for OxySure Therapeutics (OTCMKTS OXYS)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  82 (Vote Outperform)
Underperform Votes:  97 (Vote Underperform)
Total Votes:  179
MarketBeat's community ratings are surveys of what our community members think about OxySure Therapeutics and other stocks. Vote "Outperform" if you believe OXYS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OXYS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: Balance Sheet

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel